ID: ALA13201
Max Phase: Preclinical
Molecular Formula: C11H12ClNO
Molecular Weight: 209.68
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC1(C)Cc2c(Cl)cccc2C=[N+]1[O-]
Standard InChI: InChI=1S/C11H12ClNO/c1-11(2)6-9-8(7-13(11)14)4-3-5-10(9)12/h3-5,7H,6H2,1-2H3
Standard InChI Key: BLRXELABUAQKGI-UHFFFAOYSA-N
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 209.68 | Molecular Weight (Monoisotopic): 209.0607 | AlogP: 2.60 | #Rotatable Bonds: 0 |
| Polar Surface Area: 26.07 | Molecular Species: ACID | HBA: 1 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 1.14 | CX Basic pKa: | CX LogP: -0.16 | CX LogD: 1.87 |
| Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.48 | Np Likeness Score: -0.02 |
References
| 1. Bernotas RC, Thomas CE, Carr AA, Nieduzak TR, Adams G, Ohlweiler DF, Hay DA. (1996) Synthesis and radical scavenging activity of 3,3-dialkyl-3,4-dihydro-isoquinoline 2-oxides, 6 (10): [10.1016/0960-894X(96)00181-3] |
Source
Source(1):